GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
Dr. Garnier served as the CEO of GSK since its creation in 2001, steeringit through a complex merger and driving the development of one of thestrongest new product pipelines in the industry. These funds will provide anongoing tribute to his success as the leader of the world's second-largestresearch-based pharmaceutical company.
"Every successful company invests in the business to grow the bottomline," said Sir Christopher Gent, GSK Chairman. "We believe that businessshould also invest in something less tangible, less quantifiable, but of equalimportance-building its reputation with the society it serves. GSK is pleasedto honor Dr. Garnier's legacy by providing funds that will help develop thebusiness leaders of tomorrow."
"This generous gift honors an alumnus whose leadership throughout hiscareer has changed lives, changed organizations, and ultimately changed theworld," said Robert L. Joss, Dean of the Stanford Graduate School of Business."The fellowships being established in his honor ensure that Jean-PierreGarnier will continue to have an impact on shaping the next generation ofprincipled, innovative, and insightful business leaders."
Investing in the Best and Brightest
To remain competitive, Stanford Business School must attract and enrollthe best and the brightest students. The school's international reputation asa leader in management education is built on the quality and diversity of itsstudents, whose broad range of experiences and backgrounds fosters acollaborative culture. The GSK funding will provide a permanent legacy tosupport deserving students enrolled in programs at the school in two ways:
"Not only has JP Garnier's leadership had a significant impact on GSK, ithas also been felt by individuals around the world-from the establishment ofthe GSK African Malaria Partnership and the quest to eliminate lymphaticfilariasis in the developing world, to countless community partnerships," SirChristopher said. "JP Garnier has led GSK in its challenging and inspiringmission: to improve the quality of human life by enabling people to do more,feel better, and live longer. It is our hope that the recipients of theseendowments will go on to do the same in their chosen fields."
GlaxoSmithKline, one of the world's leading research-based pharmaceuticaland health care companies, is committed to improving the quality of human lifeby enabling people to do more, feel better, and live longer.
About Stanford Graduate School of Business
The Stanford Graduate School of Business, located in northern California'sSilicon Valley, enrolls approximately 740 students in the two-year full-timeMBA Program, 105 candidates in the PhD Program, 56 mid-career executives inthe 10-month Stanford Sloan Master's Program, and more than 2,000 participantsin Executive Education programs designed to enhance executives' professionalcapabilities. For more information visit: http://www.gsb.stanford.edu.-- A gift of $350,000 has been allocated to establish The JP and Danyele Garnier Fellowship Fund in the Graduate School of Business. This fund will provide a permanent legacy from which regular income will be used to underwrite tuition and fees of deserving candidates pursuing an MBA. -- A gift of $150,000 has been allocated to establish The JP and Danyele Garnier Fellowship Fund in the Graduate School of Business Summer Institute in Entrepreneurship Program. The fund will enable Stanford Busi
You May Also Like